{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:49:54Z","timestamp":1792147794823,"version":"4.4.0"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CDT"],"published-print":{"date-parts":[[2026,10,13]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Impaired mitophagy in cancer cells leads to the accumulation of dysfunctional\nmitochondria, elevated ROS, and activation of pro-survival pathways, promoting tumour\ngrowth and metabolic adaptation. ROCK2, a serine\/threonine kinase overexpressed in cancer, negatively\nregulates Parkin-mediated mitophagy, making it a rational therapeutic target.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This study used an integrated in silico pipeline to identify phytocompounds from Indian\nmedicinal plants predicted to inhibit ROCK2 and potentially modulate mitophagy. This study filtered\na library of 31,496 natural product compounds from 325 medicinal plants (IMPPAT 2.0 database)\nusing SwissADME based on Lipinski's, Veber's, Ghose's, and Pfizer's rules, yielding 598 drug-like\ncompounds. Bioactivity scoring identified 49 NPCs with kinase inhibitory potential, which underwent\nGlide SP docking against ROCK2 (PDB: 7JNT), followed by ProTox-II toxicity profiling and\nXP docking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Six compounds (Quercetin, Hydnocarpin, Annomontine, Camptothecin, 9-\nMethoxycamptothecin, and Methoxycamptothecin) showed binding affinities comparable to or exceeding\nreference inhibitors Fasudil and Y27632, with key interactions at conserved catalytic residues\n(Met172, Asp218, Asn219, Lys216). MD simulations showed that Hydnocarpin formed the\nmost stable protein-ligand complex, with a consistent RMSD, persistent hydrogen bonding with\nGlu170, Met172, and Lys216, and minimal residue fluctuations, resembling Fasudil's dynamic profile.\nQuercetin, despite favourable docking scores, showed structural instability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>Integrated docking and MD analyses indicate Hydnocarpin exhibits superior binding\nstability compared to other screened phytocompounds, suggesting more favourable predicted binding\nunder physiologically relevant simulation conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Hydnocarpin emerges as the most promising ROCK2 inhibitor among screened phytocompounds,\nsupporting its potential as a mitophagy-modulating anticancer agent warranting further\nin vitro validation, as all findings reported here are computational predictions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0113894501525537261009064503","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:25:31Z","timestamp":1792146331000},"source":"Crossref","is-referenced-by-count":0,"title":["Computational Evaluation of Hydnocarpin as a Novel ROCK2 Inhibitor and Potential Regulator of Mitophagy in Cancer"],"prefix":"10.2174","volume":"27","author":[{"given":"Aditi","family":"Kaushik","sequence":"first","affiliation":[{"name":"Centre for Emerging Diseases, Department of Biotechnology, Jaypee Institute of Information Technology, Noida, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chesta","family":"Shandilya","sequence":"additional","affiliation":[{"name":"Centre for Emerging Diseases, Department of Biotechnology, Jaypee Institute of Information Technology, Noida, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geeta","family":"Swargiary","sequence":"additional","affiliation":[{"name":"Centre for Emerging Diseases, Department of Biotechnology, Jaypee Institute of Information Technology, Noida, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saboor","family":"Khan","sequence":"additional","affiliation":[{"name":"Centre for Emerging Diseases, Department of Biotechnology, Jaypee Institute of Information Technology, Noida, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pragya","family":"Singh","sequence":"additional","affiliation":[{"name":"Centre for Emerging Diseases, Department of Biotechnology, Jaypee Institute of Information Technology, Noida, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shradheya R.R.","family":"Gupta","sequence":"additional","affiliation":[{"name":"Molecular Biology Research Lab, Department of Zoology &amp; DBC i4 Centre, Deshbandhu College, University of Delhi, Kalkaji, New Delhi, 110019, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indrakant K.","family":"Singh","sequence":"additional","affiliation":[{"name":"Molecular Biology Research Lab, Department of Zoology &amp; DBC i4 Centre, Deshbandhu College, University of Delhi, Kalkaji, New Delhi, 110019, India"},{"name":"Molecular Biology &amp; Health Informatics Lab, Dr. B. R. Ambedkar Centre for Biomedical Research, University of Delhi, Delhi, 110007, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2500-6962","authenticated-orcid":true,"given":"Shalini","family":"Mani","sequence":"additional","affiliation":[{"name":"Centre for Emerging Diseases, Department of Biotechnology, Jaypee Institute of Information Technology, Noida, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113894501525537261009064503","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/259485\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113894501525537261009064503","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:25:33Z","timestamp":1792146333000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/259485\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,13]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113894501525537261009064503","relation":{},"ISSN":["1389-4501"],"issn-type":[{"value":"1389-4501","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,13]]}}}